Stockreport

Evelo Biosciences Presents Preclinical Data for EDP1867 at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Evelo Biosciences, Inc.  (EVLO) 
Last evelo biosciences, inc. earnings: 2/13 07:00 am Check Earnings Report
PDF –Data suggest SINTAX™ medicine may overcome blood-brain barrier limitations to anti-inflammatory drug delivery– –EDP1867 reduced disease severity and incidence of relaps [Read more]